FindTrial
Sign In

A Comparative study between Intrathecal Chloroprocaine 1% and Ropivacaine 0.5%for short duration surgery

A Randomized prospective comparative study between Intrathecal Chloroprocaine 1% and Ropivacaine 0.5%for short duration surgery

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2021/09/036574
Enrollment
60
Registered
2021-09-16
Start date
Unknown
Completion date
Unknown
Last updated
2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: O- Medical and Surgical Health Condition 2: R198- Other specified symptoms and signsinvolving the digestive system and abdomen

Interventions

Intervention1: Chloroprocaine 1% intrathecal: Group R - 20mg (4ml) of 0.5% Ropivacaine intrathecal Control Intervention1: Ropivacaine 0.5%: Group C- 40 mg (4ml) of 1% Chloroprocaine

Sponsors

Teerthanker Mahaveer Medical College and Research Centre
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1.American society of Anesthesiologist (ASA) physical status I or II. 2.Patient between the age group of 18 year â?? 65 years. 3.Patients with BMI of 18.5 â?? 22.9 kg/m2.

Exclusion criteria

Exclusion criteria: 1.Patient refusal for procedure. 2.Coagulopathy. 3.Patient with spine deformity. 4.Infection at the local site. 5.Any neuropathies. 6.Pregnant female 7.Allergy to Local Anaesthetic Agent

Design outcomes

Primary

MeasureTime frame
VITAL PARAMETERS AFTER ADMINISTRATION OF CHLOROPROCAINE 1% AND ROPIVACAINE 0.5% IN TWO GROUPSTimepoint: baseline,3min,6min,9min,12min,15min,18min,21min,24min.27min,30min,35min,40min,45min,50min,60min,75min—

Secondary

MeasureTime frame
block characteristics, duration of analgesia, patientâ??s satisfaction score and any complicationsTimepoint: for every 2 mins for first 20 min,3 mins for rest 30 min, then ev ery 5 min for 40 min,every 10 min for 60 min , finally every 15 min—

Countries

India

Contacts

Public ContactDr Vivek Prakash

Teerthanker Mahaveer Medical College and Research Centre

Mukeshkumar2002@gmail.com9837624543

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026